Drug delivery, formulation

(Image: Getty/Pattanaphong Khuankaew)

Parexel launches dedicated biotech division

By Melissa Fassbender

Parexel Biotech will support emerging companies from development through commercialization with tailored services and customized guidance, says division lead.

(Image: Getty/Natali_Mis)

Digital tech exploded in 2018: Will 2019 see broad adoption?

By Melissa Fassbender

Awareness around the potential opportunities created by artificial intelligence has never been higher, but pharma’s biggest challenge in 2019 will be adopting and scaling the right technology to improve patient outcomes, says an industry executive.

(Image: Getty/kishore kumar)

5 predictions for AI in 2019

By Melissa Fassbender

While several companies touted the potential of AI to disrupt the drug development industry in 2018, what practical applications can the industry expect next year?

People on the Move: Outsourcing-Pharma roundup October '18

People on the Move: Outsourcing-Pharma roundup October '18

By Melissa Fassbender

CROs this month have made significant new hires with WCG adding eight to its scientific leadership team, PPD hiring four, and BioIVT filling its new-created role of CCO.

Also, making the move from Bioclinica, David Kiger has been named...

People on the Move: Outsourcing-Pharma roundup September '18

People on the Move: Outsourcing-Pharma roundup September '18

By Melissa Fassbender

Metrion has bolstered its drug discovery leadership team, CluePoints has upped its RBM services, and Concept Life Sciences has added to its analytical services division, among other moves this month in the outsourced pharmaceutical services industry.

(Image: Getty/pichet_w)

GA-based CDMO picked up by private equity

By Melissa Fassbender

The middle-market private equity firm Nautic Partners has acquired Mikart, an Atlanta, GA-headquartered contract development and manufacturing organization (CDMO).